This article refers to:
Article title: Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition
Authors: Fu-Yi Cai, Xue-Min Yao, Ming Jing, Liang Kong, Jing-Jing Liu, Min Fu, Xin-Ze Liu, Lu Zhang, Si-Yu He, Xue-Tao Li and Rui-Jun Ju
Journal: Journal of Liposome Research
Bibliometrics: Volume 31, Number 2, pages 113–129
DOI: https://doi.org/10.1080/08982104.2020.1745831
In the above published paper, in Figure 4(A), the picture of 24 h in group blank control was misused with group DOX liposomes. In order to avoid confusion, Figure 4(A) has been corrected and it as follows: 
This article is available both online and in print. The online version has been corrected.